|
Symbol
|
BCSBIL | MABBJB | MAPTJB | ZMAH5V | MAQGJB | MAKGJB | LVCXLK | MAFQJB | MASEJB | AHHETQ | AHHCTQ | AAZMSP | 1270BC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Barrier Express Certificate | Express Certificate | Express Certificate | Express Voncert* | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | LUKB Autocallable Multi Barrier Reverse Convertible | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | Express Certificate with European Knock-In | Express Certificate with European Knock-In | Autocallable Notes | Certificat Express |
|
Basiswert
|
Novartis AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé / Novartis / UBS / Zurich | Nestlé / Novartis / UBS / Zurich | Novo Nordisk, AstraZeneca, Roche, Novartis Basket | Barry Callebaut AG / Logitech / Novartis N |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
02.10.2030 | 04.02.2028 | 04.02.2028 | 30.04.2029 | 30.04.2029 | 30.04.2029 | 12.08.2027 | 05.01.2029 | 05.01.2029 | 22.07.2030 | 22.07.2030 | 07.10.2033 | 16.03.2029 |
| Ratio | 0,0967 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
| Geld | 101.00 | - | - | 98.00 | - | - | - | - | - | 97.13 | 97.58 | - | 103.94 |
| Brief | 101.81 | - | - | 99.00 | - | - | - | - | - | 97.93 | 98.38 | - | 104.76 |